Trial Profile
A Comparative Study of the Week 12 Antiviral Efficacy and Safety of Switching to Entecavir vs. [versus] Continuing Adefovir Treatment in Adults With Chronic Hepatitis B and Suboptimal Response to Adefovir.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Adefovir
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 08 Mar 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 08 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.